COPD Exacerbation Acute Clinical Trial
Official title:
Comparison of Bronchodilator Treatment Practices in Group E COPD Patients
Verified date | December 2023 |
Source | Ataturk University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
COPD is a heterogeneous condition caused by airway (bronchitis/bronchiolitis) or alveolar (emphysema) abnormality, changes with chronic respiratory changes (dyspnea, dyspnoea, phlegm). It is characterized by persistent and frequently progressive airway obstruction. In COPD, which progresses with high mortality, non-pharmacological treatments are applied, as well as pharmacological treatments. They have an essential place in slowing down the progressive course of this treatment. However, despite the treatment administered to COPD patients, outdoor weather conditions, improper use of inhaler treatments, or comorbidities may cause acute exacerbation of COPD. Dry air nebulizer devices use dry air from the central system in hospitals. This system, which converts bronchodilator drugs into nebulizers by creating high currents, works like classical nebulizers without an electrical system and can have a higher flow rate than jet nebulizer devices. This procedure, which can be applied to COPD patients without giving high-flow oxygen, prevents carbon dioxide retention. There is no study in the literature comparing the bronchodilator effectiveness of dry air, classical nebulizer, and jet nebulizer, and the investigators aimed to compare the efficacy of these three treatment modalities in our study.
Status | Not yet recruiting |
Enrollment | 39 |
Est. completion date | January 1, 2025 |
Est. primary completion date | April 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility | Inclusion Criteria: - Group E COPD patients Exclusion Criteria: - Recent MI - Pulmonary embolism - Cerebral aneurysm - Active hemoptysis - Pneumothorax - Nausea, vomiting - Recent thorax, abdominal, and eye surgery were identified in the patients before the pulmonary function test and were not included in the study. - Mental retardation - Pneumonia with acute exacerbation of COPD - Patients with pulmonary edema due to congestive heart failure - Patients with interstitial lung disease along with COPD |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ataturk University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the change in respiratory function test parameters after 5 days of nebulizer treatment applications.randomization on respiratory function tests | Measurement of % change in FVC, FEV1, RV, TLC level | 5 days | |
Primary | Evaluation of the change in arterial blood gas parameters after 5 days of nebulizer treatment applications.randomization on respiratory function tests | Saturation %, measurement of change in partial oxygen and partial carbon dioxide levels in mm_Hg | 5 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05418777 -
Treatment of Pneumocystis in COPD (the TOPIC Study)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Completed |
NCT03286855 -
Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
Recruiting |
NCT06021990 -
Clopidogrel for the Prevention of Exacerbations in Severe COPD
|
Phase 3 | |
Completed |
NCT05218525 -
Testing a Prediction Algorithm Into a Running Telehealth System for Patients With COPD
|
N/A | |
Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
Recruiting |
NCT05734365 -
COPD-ICU Multicentre Prospective Observational Register
|
||
Completed |
NCT03464695 -
Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD
|
N/A | |
Recruiting |
NCT04881409 -
Nasal High-flow Compared to Non-invasive Ventilation in Treatment of Acute Acidotic Hypercapnic Exacerbation of Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT05182294 -
Tolerance and Acute Effects of a New HFNT Nasal Cannula
|
N/A | |
Completed |
NCT04821869 -
ProAir Digihaler in COPD Disease Management: A Real World Study
|
||
Recruiting |
NCT06274957 -
The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation
|
N/A | |
Recruiting |
NCT05783544 -
Impact of A. Lumbricoides on Pulmonary Aspergillosis Development
|
N/A | |
Recruiting |
NCT06331416 -
Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation
|
N/A | |
Not yet recruiting |
NCT05703919 -
Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
|
Phase 4 | |
Not yet recruiting |
NCT06419062 -
The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 2
|
||
Not yet recruiting |
NCT06419036 -
The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 1
|
||
Recruiting |
NCT05764993 -
Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention
|
Phase 2 | |
Completed |
NCT06040931 -
Airway Inflammation, Small Airways Dysfunction, and Frequency of Exacerbations in COPD
|
N/A | |
Active, not recruiting |
NCT04192175 -
Identification of Patients Admitted With COPD Exacerbations and Predicting Readmission Risk Using Machine Learning
|